Wellgistics Health (NASDAQ:WGRX) Upgraded by Wall Street Zen to “Sell” Rating

Wellgistics Health (NASDAQ:WGRX) was upgraded by research analysts at Wall Street Zen to a “sell” rating in a report released on Saturday.

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Wellgistics Health in a report on Friday, March 27th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Wellgistics Health has a consensus rating of “Sell”.

Wellgistics Health Stock Down 8.1%

Shares of NASDAQ WGRX opened at $3.42 on Friday. The company has a 50 day simple moving average of $5.60 and a 200 day simple moving average of $14.95. The firm has a market cap of $8.58 million, a PE ratio of -0.08 and a beta of -1.17. Wellgistics Health has a 1 year low of $3.04 and a 1 year high of $128.00. The company has a debt-to-equity ratio of 1.86, a current ratio of 0.09 and a quick ratio of 0.03.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in WGRX. Raymond James Financial Inc. raised its holdings in Wellgistics Health by 593.8% during the 3rd quarter. Raymond James Financial Inc. now owns 58,421 shares of the company’s stock worth $52,000 after purchasing an additional 50,000 shares during the last quarter. Heights Capital Management Inc. bought a new position in Wellgistics Health during the 3rd quarter worth approximately $2,588,000. Geode Capital Management LLC raised its holdings in Wellgistics Health by 81.0% during the 4th quarter. Geode Capital Management LLC now owns 487,383 shares of the company’s stock worth $195,000 after purchasing an additional 218,170 shares during the last quarter. Finally, XTX Topco Ltd raised its holdings in Wellgistics Health by 195.1% during the 4th quarter. XTX Topco Ltd now owns 106,087 shares of the company’s stock worth $42,000 after purchasing an additional 70,137 shares during the last quarter.

Wellgistics Health Company Profile

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.